Didier Frappaz

613 total citations
11 papers, 288 citations indexed

About

Didier Frappaz is a scholar working on Oncology, Neurology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Didier Frappaz has authored 11 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Neurology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Didier Frappaz's work include Childhood Cancer Survivors' Quality of Life (2 papers), Cancer Risks and Factors (2 papers) and Glioma Diagnosis and Treatment (2 papers). Didier Frappaz is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (2 papers), Cancer Risks and Factors (2 papers) and Glioma Diagnosis and Treatment (2 papers). Didier Frappaz collaborates with scholars based in France, Tunisia and United States. Didier Frappaz's co-authors include Anne‐Isabelle Bertozzi, François Doz, Pascal Chastagner, Xavier Rialland, Denis Hémon, Olivier Hartmann, Brigitte Lacour, Jacqueline Clavel, F. Ménégaux and Pierre Leblond and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Neurosurgery.

In The Last Decade

Didier Frappaz

11 papers receiving 281 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Didier Frappaz France	8	108	82	59	58	56	11	288
Thomas Loew United States	9	105 1.0×	116 1.4×	88 1.5×	30 0.5×	78 1.4×	14	623
Mary Petriccione United States	6	109 1.0×	31 0.4×	196 3.3×	39 0.7×	32 0.6×	8	292
Daniel Alderete Argentina	10	31 0.3×	33 0.4×	84 1.4×	29 0.5×	35 0.6×	19	183
Dale Wright Australia	8	160 1.5×	23 0.3×	31 0.5×	35 0.6×	41 0.7×	23	420
Chris Mpofu Canada	11	254 2.4×	87 1.1×	254 4.3×	33 0.6×	99 1.8×	20	494
Matthew R. Hosler United States	10	201 1.9×	99 1.2×	28 0.5×	43 0.7×	17 0.3×	13	375
Tarun Sharma India	10	116 1.1×	32 0.4×	40 0.7×	50 0.9×	11 0.2×	21	372
W. Jeffrey Baker United States	8	64 0.6×	66 0.8×	109 1.8×	74 1.3×	19 0.3×	12	319
Michal Kýr Czechia	11	80 0.7×	25 0.3×	26 0.4×	68 1.2×	27 0.5×	29	284
Stephen Laughton New Zealand	7	141 1.3×	65 0.8×	138 2.3×	34 0.6×	12 0.2×	13	350

Countries citing papers authored by Didier Frappaz

Since Specialization

Citations

This map shows the geographic impact of Didier Frappaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Didier Frappaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Didier Frappaz more than expected).

Fields of papers citing papers by Didier Frappaz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Didier Frappaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Didier Frappaz. The network helps show where Didier Frappaz may publish in the future.

Co-authorship network of co-authors of Didier Frappaz

This figure shows the co-authorship network connecting the top 25 collaborators of Didier Frappaz. A scholar is included among the top collaborators of Didier Frappaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Didier Frappaz. Didier Frappaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Leblond, Pierre, Aurélie Dumont, Florence Gattacceca, et al.. (2022). Impact of pharmacogenetics on variability in exposure to oral vinorelbine among pediatric patients: a model‐based population pharmacokinetic analysis. Cancer Chemotherapy and Pharmacology. 90(1). 29–44. 4 indexed citations

Ducray, François, Didier Frappaz, Jacques Guyotat, et al.. (2016). Current trends in the management of glioblastoma in a French University Hospital and associated direct costs. Journal of Clinical Pharmacy and Therapeutics. 41(1). 47–53. 15 indexed citations

Cassier, Philippe A., Olivier Trédan, Emilie Lavergne, et al.. (2014). Identifying actionable targets in advanced cancer patients: Preliminary results from the Profiler program.. Journal of Clinical Oncology. 32(15_suppl). 2621–2621. 2 indexed citations

Aerts, Isabelle, Xavier Sastre‐Garau, Alexia Savignoni, et al.. (2013). Results of a Multicenter Prospective Study on the Postoperative Treatment of Unilateral Retinoblastoma After Primary Enucleation. Journal of Clinical Oncology. 31(11). 1458–1463. 44 indexed citations

Dufour, Christelle, Marie‐Cécile Le Deley, Franck Bourdeaut, et al.. (2011). Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system. Cancer. 118(15). 3812–3821. 76 indexed citations

Ménégaux, F., Brigitte Lacour, Olivier Hartmann, et al.. (2008). Birth characteristics and childhood malignant central nervous sytem tumors: The ESCALE study (French Society for Childhood Cancer). Cancer Detection and Prevention. 32(1). 79–86. 39 indexed citations

Plichart, Matthieu, F. Ménégaux, Brigitte Lacour, et al.. (2008). Parental smoking, maternal alcohol, coffee and tea consumption during pregnancy and childhood malignant central nervous system tumours: the ESCALE study (SFCE)*. European Journal of Cancer Prevention. 17(4). 376–383. 45 indexed citations

Mottolèse, C., et al.. (2001). Metastasis of Clear-Cell Renal Carcinoma to Cerebellar Hemangioblastoma in von Hippel Lindau Disease: Rare or not Investigated?. Acta Neurochirurgica. 143(10). 1059–1063. 28 indexed citations

Rubie, H, Dominique Plantaz, Carole Coze, et al.. (2001). Localised and unresectable neuroblastoma in infants: Excellent outcome with primary chemotherapy. Medical and Pediatric Oncology. 36(1). 247–250. 20 indexed citations

10.

Frappaz, Didier, A. Ros, G. Aubert, et al.. (1992). [Study of serum kinetics of vancomycin during the "antibiotic-lock" technique].. PubMed. 49(4). 357–60. 3 indexed citations

11.

Frappaz, Didier, Eva S. Singletary, Gary Spitzer, & Alfred Yung. (1988). Enhancement of Growth of Primary Metastatic Fresh Human Tumors of the Nervous System by Epidermal Growth Factor in Serum-free Short Term Culture. Neurosurgery. 23(3). 355–359. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact